Trial of 60 adults newly diagnosed with MS and mild to moderate depression: tailored CBT vs supportive listening gave more clinically meaningful BDI-II reductions at 8 weeks (63.3% vs 33.3%; aOR 3.62); no serious events were reported.
RCTn = 60
Kiropoulos et al. A tailored cognitive behavioural therapy intervention for depression in those newly diagnosed with multiple sclerosis (ACTION-MS): A randomised, assessor-blinded, active comparator trial